Literature DB >> 11815552

A rare complication of neonatal central venous access.

J Baker1, S Imong.   

Abstract

Total parenteral nutrition is often necessary for the survival of neonates, but obtaining central venous access can be very difficult. A case is reported in which malpositioning of a 27 gauge central venous catheter resulted in the misdiagnosis of necrotising enterocolitis and hypoglycaemia.

Entities:  

Mesh：

Year:  2002        PMID： 11815552      PMCID： PMC1721355          DOI： 10.1136/fn.86.1.f61

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


  7 in total

1.  Neonatal long lines.

Authors:  G Menon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-07       Impact factor: 5.747

2.  Unexpected course of left leg percutaneous silastic catheters.

Authors:  S Y Alabsi; D L Phelps; N Klionski
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07       Impact factor: 5.747

3.  Central venous catheters in premature babies: radiological evaluation, malpositioning and complications.

Authors:  Giampiero Beluffi; Gianfranco Perotti; Chiara Sileo; Paola Fiori; Tiziana Figar; Mauro Stronati
Journal:  Pediatr Radiol       Date:  2012-05-15

4.  Central venous lines in neonates: a study of 2186 catheters.

Authors:  D W Cartwright
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

5.  Malpositioned Central Line in A Neonate Presenting as Superficial Abdominal Abscess.

Authors:  Manasi Garg; Nishanth Rajan; Anjan Dhua; Lalitha Krishnan
Journal:  J Neonatal Surg       Date:  2017-01-01

6.  Confirming longline position in neonates - Survey of practice in England and Wales.

Authors:  Arunoday Arunoday; Christos Zipitis
Journal:  World J Clin Pediatr       Date:  2017-08-08

7.  Contrast study in umbilical venous line extravasation.

Authors:  Susan Rutendo Kamupira; James Dexter Tarr; Minju Kuruvilla
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-02-04       Impact factor: 5.747
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.